Amgen (AMGN) – Analyst Comments
-
Goldman Makes New Monthly Adjustments to Directors Cut Names, 'inclusion on this list is not a stock rating'
-
Leerink Partners Downgrades Amgen (AMGN) to Market Perform, 'Awaiting Obesity Results'
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Back to AMGN Stock Lookup